Chemoinformaics analysis of LYCOPERSICONOLIDE
Molecular Weight | 362.51 | nRot | 0 |
Heavy Atom Molecular Weight | 328.238 | nRig | 25 |
Exact Molecular Weight | 362.246 | nRing | 5 |
Solubility: LogS | -4.783 | nHRing | 1 |
Solubility: LogP | 3.486 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 22 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 62.619 |
nHD | 2 | BPOL | 36.713 |
QED | 0.649 |
Synth | 4.643 |
Natural Product Likeliness | 2.793 |
NR-PPAR-gamma | 0.525 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.96 |
Pgp-sub | 0.004 |
HIA | 0.017 |
CACO-2 | -4.814 |
MDCK | 0.0000965 |
BBB | 0.732 |
PPB | 0.907628 |
VDSS | 1.415 |
FU | 0.0523879 |
CYP1A2-inh | 0.019 |
CYP1A2-sub | 0.453 |
CYP2c19-inh | 0.053 |
CYP2c19-sub | 0.889 |
CYP2c9-inh | 0.176 |
CYP2c9-sub | 0.262 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.494 |
CYP3a4-inh | 0.457 |
CYP3a4-sub | 0.51 |
CL | 19.856 |
T12 | 0.077 |
hERG | 0.016 |
Ames | 0.024 |
ROA | 0.245 |
SkinSen | 0.304 |
Carcinogencity | 0.04 |
EI | 0.011 |
Respiratory | 0.298 |
NR-Aromatase | 0.316 |
Antiviral | No |
Prediction | 0.550194 |